Literature DB >> 2506605

Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.

P R Sanberg1, K H Russell, S H Hagenmeyer-Houser, M Giordano, E M Zubrycki, D L Garver.   

Abstract

Most investigators have found a decrease in emotional defecation in rats given neuroleptics in novel environments, supporting their action as a major tranquilizer. We have found, however, that in rats a profound increase in emotional defecation can result from neuroleptic administration in well habituated environments, such as the homecage. Anticholinergics are known to be effective in treating the side effects associated with neuroleptic administration in humans. Therefore the present study determined the effects of anticholinergic treatment in this animal model. In male rats, defecation was measured for a 1-h test period in their homecage following various doses of the central and peripheral anticholinergics, scopolamine, and n-methylscopolamine, respectively. A decrease in fecal excretions and an attenuation of haloperidol-induced defecation was found following administration of scopolamine. n-Methylscopolamine reduced defecation at all doses. When n-methylscopolamine was combined with haloperidol, both fecal mass and number decreased significantly. Since both anticholinergic agents reduced haloperidol-induced defecation it is suggested that their effectiveness is mediated through peripheral mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506605     DOI: 10.1007/bf00634453

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Determinants of emotionality in the rat. I. Situational factors.

Authors:  P L BROADHURST
Journal:  Br J Psychol       Date:  1957-02

Review 2.  The catalepsy test: its ups and downs.

Authors:  P R Sanberg; M D Bunsey; M Giordano; A B Norman
Journal:  Behav Neurosci       Date:  1988-10       Impact factor: 1.912

3.  Are emotion and motivation localized in the limbic system and nucleus accumbens?

Authors:  C H Vanderwolf; M E Kelly; P Kraemer; A Streather
Journal:  Behav Brain Res       Date:  1988-01       Impact factor: 3.332

4.  Effects of psychotropic drugs on emotional behavior: exploratory behavior of naive rats in holed open field.

Authors:  M Nakama; T Ochiai; Y Kowa
Journal:  Jpn J Pharmacol       Date:  1972-12

5.  [Action of some psychotropic drugs on emotional defecation in mice].

Authors:  P Allain; P Lechat
Journal:  Therapie       Date:  1970 Jul-Aug       Impact factor: 2.070

Review 6.  Glutamate and Huntington's disease.

Authors:  P R Sanberg; G A Johnston
Journal:  Med J Aust       Date:  1981-10-31       Impact factor: 7.738

7.  Dopaminergic and cholinergic influences on motor behavior in chickens.

Authors:  P R Sanberg
Journal:  J Comp Psychol       Date:  1983-03       Impact factor: 2.231

8.  School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder.

Authors:  E J Mikkelsen; J Detlor; D J Cohen
Journal:  Am J Psychiatry       Date:  1981-12       Impact factor: 18.112

9.  Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.

Authors:  P R Sanberg
Journal:  Nature       Date:  1980-04-03       Impact factor: 49.962

10.  Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome.

Authors:  R Milo
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

View more
  3 in total

1.  [The initial dysphoric reaction (IDR) to the first dose of neuroleptics].

Authors:  B Graf Schimmelmann; M Schacht; C Perro; M Lambert
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

2.  Drug-induced defaecation in rats: role of central 5-HT1A receptors.

Authors:  T Croci; M Landi; A Bianchetti; L Manara
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 3.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.